• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GBI
Click for more information
0.00% 0.0¢

GENERA BIOSYSTEMS LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
GBITrading HaltPRICE SENSITIVE30/04/12
GBIGenera Biosystems Business UpdatePRICE SENSITIVE24/04/12
GBIHalf Yearly Report and AccountsPRICE SENSITIVE27/02/12
GBIAppendix 4C - quarterly and Business UpdatePRICE SENSITIVE31/01/12
GBIConclusion of PapType UK clinical studyPRICE SENSITIVE02/11/11
GBIAppendix 4C - quarterlyPRICE SENSITIVE27/10/11
GBIPreliminary Final ReportPRICE SENSITIVE26/08/11
GBIConclusion of agreement with research partnerPRICE SENSITIVE17/08/11
GBIAppendix 4C - quarterlyPRICE SENSITIVE27/07/11
GBIBusiness update, Outcome of Strategic ReviewPRICE SENSITIVE04/07/11
GBIAppendix 4C - quarterlyPRICE SENSITIVE29/04/11
GBIRights Issue closure and shortfall, Proposed Option IssuePRICE SENSITIVE01/04/11
GBIGrant of Key US PatentPRICE SENSITIVE23/03/11
GBIFurther milestone payment received from partnerPRICE SENSITIVE21/03/11
GBINon-renounceable rights issue documentsPRICE SENSITIVE28/02/11
GBIHalf Yearly Report and AccountsPRICE SENSITIVE24/02/11
GBICommercialisation Update, Capital Raising UpdatePRICE SENSITIVE23/02/11
GBITrading HaltPRICE SENSITIVE21/02/11
GBIAppendix 4C - quarterlyPRICE SENSITIVE31/01/11
GBIMilestone payment received from partnerPRICE SENSITIVE06/01/11
GBIChairman's Address to ShareholdersPRICE SENSITIVE25/11/10
GBIAppendix 4C - quarterlyPRICE SENSITIVE29/10/10
GBIAppendix 4E Preliminary Final ReportPRICE SENSITIVE30/08/10
GBIAppendix 4C - quarterlyPRICE SENSITIVE23/07/10
GBIGBI Major R and D Alliance with Top 10 Diagnostic CompanyPRICE SENSITIVE24/05/10
GBI +GBI agreement with HSP on novel respiratory pathen testPRICE SENSITIVE11/05/10
GBIAppendix 4C - quarterlyPRICE SENSITIVE30/04/10
GBIGenera CE Marks PapType ProductPRICE SENSITIVE19/04/10
GBIAppendix 4D Half Yearly Report and AccountsPRICE SENSITIVE18/02/10
GBIAppendix 4C - quarterlyPRICE SENSITIVE29/01/10
GBIRegulatory Notice on PapType at end of Trading Halt periodPRICE SENSITIVE22/01/10
GBITrading HaltPRICE SENSITIVE20/01/10
GBITGA Application for PapTypePRICE SENSITIVE19/11/09
GBIPlacementPRICE SENSITIVE05/11/09
GBIAppendix 4C - quarterlyPRICE SENSITIVE22/10/09
GBIQuality System Certification and Licence to ManufacturePRICE SENSITIVE15/10/09
GBIResults of Major Clinical Study-Genera Biosystems' PapTypePRICE SENSITIVE04/09/09
GBIAppendix 4E Preliminary Final ReportPRICE SENSITIVE26/08/09
GBIAppendix 4C - quarterlyPRICE SENSITIVE27/07/09
GBITrading HaltPRICE SENSITIVE15/05/09
GBIAppendix 4C - quarterly and Company UpdatePRICE SENSITIVE30/04/09
GBIPapType cervical cancer test- data release.PRICE SENSITIVE08/04/09
GBIAppendix 4D Half Yearly Report and AccountsPRICE SENSITIVE24/02/09
GBIAppendix 4C - quarterlyPRICE SENSITIVE22/01/09
GBIClarification of Media Report in the AFR 21st January 09PRICE SENSITIVE21/01/09
GBIAustralian Patent GrantedPRICE SENSITIVE09/01/09
GBITrading Halt
30/04/12PRICE SENSITIVE
GBIGenera Biosystems Business Update
24/04/12PRICE SENSITIVE
GBIHalf Yearly Report and Accounts
27/02/12PRICE SENSITIVE
GBIAppendix 4C - quarterly and Business Update
31/01/12PRICE SENSITIVE
GBIConclusion of PapType UK clinical study
02/11/11PRICE SENSITIVE
GBIAppendix 4C - quarterly
27/10/11PRICE SENSITIVE
GBIPreliminary Final Report
26/08/11PRICE SENSITIVE
GBIConclusion of agreement with research partner
17/08/11PRICE SENSITIVE
GBIAppendix 4C - quarterly
27/07/11PRICE SENSITIVE
GBIBusiness update, Outcome of Strategic Review
04/07/11PRICE SENSITIVE
GBIAppendix 4C - quarterly
29/04/11PRICE SENSITIVE
GBIRights Issue closure and shortfall, Proposed Option Issue
01/04/11PRICE SENSITIVE
GBIGrant of Key US Patent
23/03/11PRICE SENSITIVE
GBIFurther milestone payment received from partner
21/03/11PRICE SENSITIVE
GBINon-renounceable rights issue documents
28/02/11PRICE SENSITIVE
GBIHalf Yearly Report and Accounts
24/02/11PRICE SENSITIVE
GBICommercialisation Update, Capital Raising Update
23/02/11PRICE SENSITIVE
GBITrading Halt
21/02/11PRICE SENSITIVE
GBIAppendix 4C - quarterly
31/01/11PRICE SENSITIVE
GBIMilestone payment received from partner
06/01/11PRICE SENSITIVE
GBIChairman's Address to Shareholders
25/11/10PRICE SENSITIVE
GBIAppendix 4C - quarterly
29/10/10PRICE SENSITIVE
GBIAppendix 4E Preliminary Final Report
30/08/10PRICE SENSITIVE
GBIAppendix 4C - quarterly
23/07/10PRICE SENSITIVE
GBIGBI Major R and D Alliance with Top 10 Diagnostic Company
24/05/10PRICE SENSITIVE
GBI +GBI agreement with HSP on novel respiratory pathen test
11/05/10PRICE SENSITIVE
GBIAppendix 4C - quarterly
30/04/10PRICE SENSITIVE
GBIGenera CE Marks PapType Product
19/04/10PRICE SENSITIVE
GBIAppendix 4D Half Yearly Report and Accounts
18/02/10PRICE SENSITIVE
GBIAppendix 4C - quarterly
29/01/10PRICE SENSITIVE
GBIRegulatory Notice on PapType at end of Trading Halt period
22/01/10PRICE SENSITIVE
GBITrading Halt
20/01/10PRICE SENSITIVE
GBITGA Application for PapType
19/11/09PRICE SENSITIVE
GBIPlacement
05/11/09PRICE SENSITIVE
GBIAppendix 4C - quarterly
22/10/09PRICE SENSITIVE
GBIQuality System Certification and Licence to Manufacture
15/10/09PRICE SENSITIVE
GBIResults of Major Clinical Study-Genera Biosystems' PapType
04/09/09PRICE SENSITIVE
GBIAppendix 4E Preliminary Final Report
26/08/09PRICE SENSITIVE
GBIAppendix 4C - quarterly
27/07/09PRICE SENSITIVE
GBITrading Halt
15/05/09PRICE SENSITIVE
GBIAppendix 4C - quarterly and Company Update
30/04/09PRICE SENSITIVE
GBIPapType cervical cancer test- data release.
08/04/09PRICE SENSITIVE
GBIAppendix 4D Half Yearly Report and Accounts
24/02/09PRICE SENSITIVE
GBIAppendix 4C - quarterly
22/01/09PRICE SENSITIVE
GBIClarification of Media Report in the AFR 21st January 09
21/01/09PRICE SENSITIVE
GBIAustralian Patent Granted
09/01/09PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Tambourah chases gold veins and mineralisation extension with drilling Tambourah Metals Ltd has discovered two high-grade gold veins through a diamond drilling program in Western Australia
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.